GlassScriptPhysician profile
Elizabeth A Murray
NPI 1508151010
$4,633.25
in general payments reported to CMS, 2019-2025
43 companies · $381 in 2025
The $381 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.36 · 2020: $187 · 2021: $561 · 2022: $1,151 · 2023: $1,143 · 2024: $1,189 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,713.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,712.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $627.95 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Pfizer INC. | $463.89 | 2021-2025 | |
| Novo Nordisk INC | $432.50 | 2020-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $298.19 | 2021-2025 | |
| Vanda Pharmaceuticals INC. | $257.08 | 2021-2023 | Hetlioz |
| Novartis Pharmaceuticals Corporation | $240.83 | 2021-2023 | |
| Esperion Therapeutics, INC. | $225.19 | 2020-2024 | Nexletol |
| Glaxosmithkline, LLC. | $203.49 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $193.42 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $144.54 | 2023-2025 | Gemtesa |
| Amgen INC. | $140.83 | 2020-2025 | Otezla, Repatha, Repatha |
| Dexcom, INC. | $137.44 | 2023-2024 | Dexcom G6 Transmitter |
| Medline Industries LP | $117.47 | 2024-2025 | Medline |
| Exact Sciences Corporation | $115.82 | 2023-2024 | Cologuard Collection Kit |
| Sunovion Pharmaceuticals INC. | $98.40 | 2021-2022 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.